Natixis Advisors LLC Grows Position in Stevanato Group S.p.A. (NYSE:STVN)

Natixis Advisors LLC grew its position in shares of Stevanato Group S.p.A. (NYSE:STVN) by 5.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 54,128 shares of the company’s stock after acquiring an additional 2,785 shares during the quarter. Natixis Advisors LLC’s holdings in Stevanato Group were worth $1,179,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Conestoga Capital Advisors LLC boosted its holdings in Stevanato Group by 5.3% during the fourth quarter. Conestoga Capital Advisors LLC now owns 8,082,996 shares of the company’s stock worth $176,128,000 after purchasing an additional 407,086 shares during the last quarter. TimesSquare Capital Management LLC lifted its position in shares of Stevanato Group by 114.6% during the 4th quarter. TimesSquare Capital Management LLC now owns 3,288,529 shares of the company’s stock worth $71,657,000 after buying an additional 1,756,100 shares in the last quarter. Wellington Management Group LLP boosted its stake in shares of Stevanato Group by 4.5% in the 3rd quarter. Wellington Management Group LLP now owns 2,693,588 shares of the company’s stock worth $53,872,000 after buying an additional 115,050 shares during the last quarter. Bamco Inc. NY grew its holdings in shares of Stevanato Group by 1.3% in the third quarter. Bamco Inc. NY now owns 1,685,181 shares of the company’s stock valued at $33,704,000 after acquiring an additional 21,469 shares in the last quarter. Finally, Fred Alger Management LLC increased its position in shares of Stevanato Group by 24.2% during the third quarter. Fred Alger Management LLC now owns 1,070,557 shares of the company’s stock valued at $21,411,000 after acquiring an additional 208,830 shares during the last quarter.

Stevanato Group Stock Performance

NYSE STVN opened at €21.26 ($22.86) on Wednesday. The company’s 50 day moving average is €21.03 and its 200-day moving average is €20.59. The firm has a market cap of $6.44 billion, a P/E ratio of 45.23, a price-to-earnings-growth ratio of 7.18 and a beta of 0.60. Stevanato Group S.p.A. has a 12-month low of €16.56 ($17.81) and a 12-month high of €33.49 ($36.01). The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22.

Stevanato Group (NYSE:STVN) last issued its earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of €0.20 ($0.22). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The business had revenue of €352.68 million for the quarter, compared to analysts’ expectations of €346.26 million. Sell-side analysts predict that Stevanato Group S.p.A. will post 0.5 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on STVN. William Blair restated an “outperform” rating on shares of Stevanato Group in a research note on Friday, March 7th. Wolfe Research initiated coverage on shares of Stevanato Group in a research report on Friday, December 13th. They set an “outperform” rating and a $28.00 price target for the company. UBS Group lowered their price objective on shares of Stevanato Group from $24.00 to $23.50 and set a “neutral” rating on the stock in a research report on Friday, March 7th. Morgan Stanley reissued an “equal weight” rating and set a $23.00 target price (down from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. Finally, Bank of America upped their price objective on Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a research note on Friday, December 13th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of €25.70 ($27.63).

Stevanato Group Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.